Cite

    Frias, J. et al. (2020). Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial. Diabetes, obesity & metabolism. 22 (7), pp. 1083-1093. [Online].